Literature DB >> 9113510

The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite.

J A Bridgewater1, R J Knox, J D Pitts, M K Collins, C J Springer.   

Abstract

The bystander effect is an important part of tumor kill using gene-directed enzyme prodrug therapy (GDEPT). Recently, we have described a novel enzyme prodrug system using bacterial nitroreductase and the prodrug CB1954 (NTR/CB1954). We demonstrate here the presence of a cell-permeable cytotoxic activity in the conditioned growth medium of nitroreductase (NTR)-transduced cells treated with CB1954 and show that its appearance corresponds to the appearance of two metabolites of CB1954 previously identified (Friedlos et al., 1992). The degree of bystander effect and the degree of transferred cytotoxicity correlates with the level of NTR enzyme expression. Two other prodrugs for NTR show little bystander killing and do not produce detectable cell permeable metabolites. The elucidation of the mechanism of the bystander effect may allow the more effective use of NTR/CB1954.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9113510     DOI: 10.1089/hum.1997.8.6-709

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  27 in total

1.  Cone degeneration following rod ablation in a reversible model of retinal degeneration.

Authors:  Rene Y Choi; Gustav A Engbretson; Eduardo C Solessio; Georgette A Jones; Adam Coughlin; Ilija Aleksic; Michael E Zuber
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

Review 2.  Gene-directed enzyme prodrug therapy.

Authors:  Jin Zhang; Vijay Kale; Mingnan Chen
Journal:  AAPS J       Date:  2014-10-23       Impact factor: 4.009

Review 3.  Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.

Authors:  Sonia Tusell Wennier; Jia Liu; Grant McFadden
Journal:  Curr Pharm Biotechnol       Date:  2012-07       Impact factor: 2.837

4.  A novel model of retinal ablation demonstrates that the extent of rod cell death regulates the origin of the regenerated zebrafish rod photoreceptors.

Authors:  Jacob E Montgomery; Michael J Parsons; David R Hyde
Journal:  J Comp Neurol       Date:  2010-03-15       Impact factor: 3.215

5.  Enhanced cell-specific ablation in zebrafish using a triple mutant of Escherichia coli nitroreductase.

Authors:  Jonathan R Mathias; Zhanying Zhang; Meera T Saxena; Jeff S Mumm
Journal:  Zebrafish       Date:  2014-01-15       Impact factor: 1.985

6.  Nitroreductase-mediated cell/tissue ablation in zebrafish: a spatially and temporally controlled ablation method with applications in developmental and regeneration studies.

Authors:  Silvia Curado; Didier Y R Stainier; Ryan M Anderson
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

7.  A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].

Authors:  Prashant Patel; J Graham Young; Vivien Mautner; Daniel Ashdown; Sarah Bonney; Robert G Pineda; Stuart I Collins; Peter F Searle; Diana Hull; Elizabeth Peers; John Chester; D Michael Wallace; Alan Doherty; Hing Leung; Lawrence S Young; Nicholas D James
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

8.  SP94-Targeted Triblock Copolymer Nanoparticle Delivers Thymidine Kinase-p53-Nitroreductase Triple Therapeutic Gene and Restores Anticancer Function against Hepatocellular Carcinoma in Vivo.

Authors:  Uday K Sukumar; Jagadesh Chandra Bose Rajendran; Sanjiv S Gambhir; Tarik F Massoud; Ramasamy Paulmurugan
Journal:  ACS Appl Mater Interfaces       Date:  2020-03-02       Impact factor: 9.229

9.  Thymic epithelial requirement for γδ T cell development revealed in the cell ablation transgenic system with TSCOT promoter.

Authors:  Gwanghee Lee; Ki Yeon Kim; Cheong-Hee Chang; Moon Gyo Kim
Journal:  Mol Cells       Date:  2012-11-15       Impact factor: 5.034

Review 10.  Modifications of human carboxylesterase for improved prodrug activation.

Authors:  Jason M Hatfield; Monika Wierdl; Randy M Wadkins; Philip M Potter
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-09       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.